New study seeks to unlock immune secrets behind deadly fungal infections in ICU patients
NCT ID NCT07130799
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the immune system responds in critically ill patients with severe abdominal infections. Researchers want to understand why some patients develop a serious fungal infection while others do not. They will measure a specific immune marker (HLA-DR) in 100 adults after emergency abdominal surgery. The goal is to improve early detection and risk assessment for fungal infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANDIDA SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHRU de NANCY
RECRUITINGVandœuvre-lès-Nancy, 54500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- A gentle touch from family may calm the ICU storm
- Can remote exercise rebuild strength in kids after ICU?
- Fasting in the ICU: a metabolic key to immune response?